Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract 5019: Comprehensive pan-cancer analysis of cfDNA methylation marks in tumors reveals complex epigenetic regulatory circuits and diagnostic biomarkers

Cancer Res (2024) 84 (6_Supplement): 5019.

https://doi.org/10.1158/1538-7445.AM2024-5019

Published: 22 March 2024

View articletitled, Abstract 5019: Comprehensive pan-cancer analysis of cfDNA methylation marks in tumors reveals complex epigenetic regulatory circuits and diagnostic biomarkers

Journal Articles

Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway

Yuhong Lu, Yanfeng Liu, Sebastian Oeck, Gary J. Zhang, Alexander Schramm, Peter M. Glazer

Cancer Res (2020) 80 (21): 4655–4667.

https://doi.org/10.1158/0008-5472.CAN-20-1192

Published: 03 November 2020

View articletitled, Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway

Includes: Supplementary data

Journal Articles

Abstract 4731: Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma

Anton Henssen, Kristina Althoff, Richard Koche, Andrea Odersky, Anneleen Beckers, Frank Speleman, Simon Schäfers, Katleen De Preter, Alexandra Florin, Lukas Heukamp, Annika Spruessel, Kathy Astrahanseff, Natalie Sadowski, Alexander Schramm, Angelika Eggert, Lucile Astorgues-Xerri, Eugenia Riveiro, Esteban Cvitkovic, Johannes H. Schulte

Cancer Res (2015) 75 (15_Supplement): 4731.

https://doi.org/10.1158/1538-7445.AM2015-4731

Published: 01 August 2015

View articletitled, Abstract 4731: Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma

Journal Articles

Abstract LB-210: Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Martin Peifer, Frederik Roels, Falk Hertwig, Roopika Menon, Andrea Kraemer, Reinhard Buettner, Sven Perner, Alexander Schramm, Johannes H. Schulte, Frank Westermann, Roman K. Thomas, Matthias Fischer

Cancer Res (2015) 75 (15_Supplement): LB-210.

https://doi.org/10.1158/1538-7445.AM2015-LB-210

Published: 01 August 2015

View articletitled, Abstract LB-210: Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Journal Articles

Abstract 3967: BET protein inhibitor OTX015 has selective anti-tumoral activity in preclinical models of MYCN- amplified neuroblastoma

Johannes H. Schulte, Kristina Althoff, Emma Bell, Andrea Odersky, Anneleen Beckers, Frank Speleman, Simon Schäfers, Alexander Schramm, Angelika Eggert, Frank Westermann, Eugenia Riveiro, Esteban Cvitkovic, Anton Henssen

Cancer Res (2014) 74 (19_Supplement): 3967.

https://doi.org/10.1158/1538-7445.AM2014-3967

Published: 01 October 2014

View articletitled, Abstract 3967: BET protein inhibitor OTX015 has selective anti-tumoral activity in preclinical models of MYCN- amplified neuroblastoma

Journal Articles

Abstract 4596: LIN28B drives neuroblastoma oncogenesis through let7-MYCN signaling.

Johannes H. Schulte, Jan Molenaar, Sven Lindner, Alexander Schramm, Pieter Mestdagh, Frank Speleman, Rogier Versteeg, Angelika Eggert

Cancer Res (2013) 73 (8_Supplement): 4596.

https://doi.org/10.1158/1538-7445.AM2013-4596

Published: 15 April 2013

View articletitled, Abstract 4596: LIN28B drives neuroblastoma oncogenesis through let7-MYCN signaling.

Journal Articles

Smac Mimetic LBW242 Sensitizes XIAP-Overexpressing Neuroblastoma Cells for TNF-α–Independent Apoptosis

Georg Eschenburg, Angelika Eggert, Alexander Schramm, Holger N. Lode, Patrick Hundsdoerfer

Cancer Res (2012) 72 (10): 2645–2656.

https://doi.org/10.1158/0008-5472.CAN-11-4072

Published: 14 May 2012

View articletitled, Smac Mimetic LBW242 Sensitizes XIAP-Overexpressing Neuroblastoma Cells for TNF-α–Independent Apoptosis

Includes: Supplementary data

Journal Articles

Abstract 1683: ALK F1174L kinase activity as driver of cell proliferation in neuroblastoma cell line models and neuroblastoma tumors

Riet Hilhorst, Liesbeth Hovestad, Rik de Wijn, Dirk Pijnenburg, Rob Ruijtenbeek, Alexander Schramm, Angelika Eggert, Johannes H. Schulte

Cancer Res (2012) 72 (8_Supplement): 1683.

https://doi.org/10.1158/1538-7445.AM2012-1683

Published: 15 April 2012

View articletitled, Abstract 1683: ALK F1174L kinase activity as driver of cell proliferation in neuroblastoma cell line models and neuroblastoma tumors

Journal Articles

Abstract #5614: The AA genotype of the regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma

Hagen Bachmann, Lukas Heukam, Klaus Schmitz, Carolin Hilburn, Philip Kahl, Reinhard Buettner, Holger Nueckel, Kurt Schmid, Winfried Sieffert, Angelika Eggert, Alexander Schramm, Johannes Schulte

Cancer Res (2009) 69 (9_Supplement): 5614.

Published: 01 May 2009

View articletitled, Abstract #5614: The AA genotype of the regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma

Journal Articles

Abstract #486: The histone demethylase LSD1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy

Johannes Schulte, So-Young Lim, Steffi Kuhfittig-Kulle, Alexander Schramm, Kristian Pajtler, Nicolaus Friedrichs, Jan Koster, Ingrid Ora, Rogier Versteeg, Roland Schuele, Reinhard Buettner, Eric Metzger, Kirfel Jutta, Angelika Eggert

Cancer Res (2009) 69 (9_Supplement): 486.

Published: 01 May 2009

View articletitled, Abstract #486: The histone demethylase LSD1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy

Journal Articles

Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

Johannes H. Schulte, Soyoung Lim, Alexander Schramm, Nicolaus Friedrichs, Jan Koster, Rogier Versteeg, Ingrid Ora, Kristian Pajtler, Ludger Klein-Hitpass, Steffi Kuhfittig-Kulle, Eric Metzger, Roland Schüle, Angelika Eggert, Reinhard Buettner, Jutta Kirfel

Cancer Res (2009) 69 (5): 2065–2071.

https://doi.org/10.1158/0008-5472.CAN-08-1735

Published: 02 March 2009

View articletitled, Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

Includes: Supplementary data

Journal Articles

N-myc Regulates Oncogenic microRNAs in neuroblastoma

Johannes Schulte, Sebastian Horn, Birgit Samans, Lukas Heukamp, Ursula-Christa Eilers, Tobias Otto, Michael Krause, Kathy Astrahantseff, Reinhard Buettner, Alexander Schramm, Holger Christiansen, Martin Eilers, Angelika Eggert, Bernd Berwanger

Cancer Res (2007) 67 (9_Supplement): 4512.

Published: 01 May 2007

View articletitled, N-myc Regulates Oncogenic microRNAs in neuroblastoma

Journal Articles

Fractalkine (CX3CL1) rich neuroblastoma microenvironments favor T-cell mediated eradication of metastases following targeted IL-2 immuncytokine therapy

Holger Lode, Yan Zeng, Nicole Huebener, Stefan Fest, Ulrike Schroeder, Silke Weixler, Alexander Schramm, Angelika Eggert, Gerhard Gaedicke

Cancer Res (2007) 67 (9_Supplement): 517.

Published: 01 May 2007

View articletitled, Fractalkine (CX3CL1) rich neuroblastoma microenvironments favor T-cell mediated eradication of metastases following targeted IL-2 immuncytokine therapy

Journal Articles

Translation of microarray results into a clinical format for predicting neuroblastoma relapse

Alexander Schramm, Lars Kaderali, Jo Vandesompele, Johannes Schulte, Benedikt Brors, Roland Eils, Frank Speleman, Angelika Eggert

Cancer Res (2007) 67 (9_Supplement): 2707.

Published: 01 May 2007

View articletitled, Translation of microarray results into a clinical format for predicting neuroblastoma relapse

Journal Articles

Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Yan Zeng, Nicole Huebener, Stefan Fest, Silke Weixler, Ulrike Schroeder, Gerhard Gaedicke, Rong Xiang, Alexander Schramm, Angelika Eggert, Ralph A. Reisfeld, Holger N. Lode

Cancer Res (2007) 67 (5): 2331–2338.

https://doi.org/10.1158/0008-5472.CAN-06-3041

Published: 01 March 2007

View articletitled, Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Journal Articles

Keratoepithelin Suppresses the Progression of Experimental Human Neuroblastomas

Jürgen Becker, Bernhard Erdlenbruch, Ievgeniia Noskova, Alexander Schramm, Monique Aumailley, Daniel F. Schorderet, Lothar Schweigerer

Cancer Res (2006) 66 (10): 5314–5321.

https://doi.org/10.1158/0008-5472.CAN-05-3049

Published: 16 May 2006

View articletitled, Keratoepithelin Suppresses the Progression of Experimental Human Neuroblastomas

Journal Articles

Differential Effects of TrkA or TrkB Expression on DNA Repair Capacity Might Contribute to the Genomic Stability of SY5Y Neuroblastoma Cells

Johannes H. Schulte, Steffi Kuhfittig-Kulle, Daniela Dobrzinski, Alexander Schramm, Elke Feldmann, Ludger Klein-Hitpass, Harald Stephan, Werner Havers, Petra Pfeiffer, Angelika Eggert

Cancer Res (2005) 65 (9_Supplement): 689–690.

Published: 01 May 2005

View articletitled, Differential Effects of TrkA or TrkB Expression on DNA Repair Capacity Might Contribute to the Genomic Stability of SY5Y Neuroblastoma Cells

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 5019: Comprehensive pan-cancer analysis of cfDNA methylation marks in tumors reveals complex epigenetic regulatory circuits and diagnostic biomarkers

Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway

Abstract 4731: Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma

Abstract LB-210: Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Abstract 3967: BET protein inhibitor OTX015 has selective anti-tumoral activity in preclinical models of MYCN- amplified neuroblastoma

Abstract 4596: LIN28B drives neuroblastoma oncogenesis through let7-MYCN signaling.

Smac Mimetic LBW242 Sensitizes XIAP-Overexpressing Neuroblastoma Cells for TNF-α–Independent Apoptosis

Abstract 1683: ALK F1174L kinase activity as driver of cell proliferation in neuroblastoma cell line models and neuroblastoma tumors

Abstract #5614: The AA genotype of the regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma

Abstract #486: The histone demethylase LSD1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy

Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

N-myc Regulates Oncogenic microRNAs in neuroblastoma

Fractalkine (CX3CL1) rich neuroblastoma microenvironments favor T-cell mediated eradication of metastases following targeted IL-2 immuncytokine therapy

Translation of microarray results into a clinical format for predicting neuroblastoma relapse

Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Keratoepithelin Suppresses the Progression of Experimental Human Neuroblastomas

Differential Effects of TrkA or TrkB Expression on DNA Repair Capacity Might Contribute to the Genomic Stability of SY5Y Neuroblastoma Cells

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only